JANUARY 1 – JUNE 30, 2011
- Net sales for the period totaled SEK 47.6 M (60.9)
- Profit after tax was SEK 1.3 M (17.4) corresponding to earnings per share of SEK 0.04 (0.51)
- Operating profit totaled SEK 2.0 M (23.8)
- Cash flow was a negative SEK 27.0 M (pos: 2.1)
- RaySearch established a sales organization in the US in January
- Two new orders for RayStation® from Switzerland and Canada were received in February
- RaySearch licensed pioneering technology from Princess Margaret Hospital in March
- A clinic in the Netherlands placed an order for RayStation® in April
- RaySearch became involved in a US patent dispute in May
AFTER THE END OF THE PERIOD
- Three US cancer centers placed orders for RayStation® in August
“Financially, the first six months of the year were weak. The profit is declining faster than the revenues due to the investment in our proprietary RayStation® treatment planning system where costs were incurred for development, marketing and the build-up of the sales and service organizations, but we have not yet benefitted from significant revenues from the product,” says Johan Löf, President of RaySearch.
“We are however starting to see results from our RayStation® sales effort. In August, we announced three new orders from clinics in New Jersey and New York with a combined order value exceeding one million US dollars,” concludes Johan Löf.
FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
Johan Löf, President
Tel: +46 (0)8-545 061 30
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are mainly sold through license agreements with leading partners such as Philips, Nucletron, IBA Dosimetry, Varian, TomoTherapy and Siemens. To date, 15 products have been launched through partners and RaySearch’s software is used at some 1,800 clinics in more than 30 countries. In addition, RaySearch offers the proprietary treatment planning system RayStation® directly to clinics. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.
For more information about RaySearch, visit www.raysearchlabs.com.